The higher expression of PPARGC1A was correlated with high tumor purity in CHOL, GBM, KIRC, KIRP, and THCA, while with low stromal scores of BLCA, HNSC, LUSC, and TGCT, which was the opposite to the pattern of PPARGC1B. Here, PPARGC1B is linked to neoplasm.